Article: ALS Therapy Development Foundation to Present at Massachusetts Biotechnology Council Annual Meeting; Founding Director James Heywood to Participate in Venture Philanthropy Panel.

NEWTON, Mass. -- NEWTON, Mass., April 22 /PRNewswire/ -- The ALS Therapy Development Foundation (ALS-TDF) today announced that James Allen Heywood, Founding Director of ALS-TDF, will participate in a panel session entitled "Venture Philanthropy: New Money for New Cures" at the Massachusetts Biotechnology Council's 2003 Annual Meeting in Boston on Thursday, April 24th at 2:30 p.m.

Mr. Heywood will be speaking on ALS-TDF's "nonprofit biotechnology" business model and on the opportunities it presents to industry partners. Founded in 1999, the ALS Therapy Development Foundation runs the largest drug discovery program for Amyotrophic Lateral Sclerosis (ALS, or Lou ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!